Click a link below to view the mailing archive as if it had been sent to you.
| 2020-11-30 12:15 | | Novavax, swamped with FDA's manufacturing 'questions,' hopes for U.S. coronavirus shot trial by the end of the year and more... |
| 2020-11-30 00:15 | | Gilead's New CEO Is Going All-In on Acquisitions and more... |
| 2020-11-28 00:15 | | Biogen stocks up on Sage's brain drugs in $3B deal and more... |
| 2020-11-26 00:15 | | Azar says states will decide who gets first Covid-19 shots and more... |
| 2020-11-25 12:15 | | Covaxx inks supply deals worth $2.8B in lead-up to coronavirus vaccine midstage trials and more... |
| 2020-11-25 00:15 | | Purdue Pharma pleads guilty in federal OxyContin probe, formally recognizing it played a part in the opioid crisis and more... |
| 2020-11-24 12:15 | | GlaxoSmithKline takes RSV maternal vaccine candidate into Phase 3 study and more... |
| 2020-11-24 00:15 | | Moderna to file COVID-19 shot for emergency nod in November, with Pfizer rollout pegged for early next month: Slaoui and more... |
| 2020-11-23 12:15 | | AstraZeneca's COVID-19 vaccine 70% effective, shares fall and more... |
| 2020-11-23 00:15 | | Regeneron COVID-19 drug, used to treat Trump, cleared for emergency use and more... |
| 2020-11-22 00:15 | | Where Will Vaxart Be in 1 Year? and more... |
| 2020-11-20 12:15 | | Pfizer seeking emergency use of its COVID-19 vaccine in US today and more... |
| 2020-11-20 00:15 | | COVID-19 Vaccine Rollout Timeline: Possibly Beginning Distribution in December and more... |
| 2020-11-19 12:15 | | AstraZeneca's COVID-19 vaccine shows midphase promise in seniors and more... |
| 2020-11-19 00:15 | | Pharvaris lands another $80M as it looks to tackle Takeda and CSL with an oral approach for HAE and more... |
| 2020-11-18 12:15 | | Cerebral Therapeutics announces enrolment of first patient in phase 2b trial in epilepsy and more... |
| 2020-11-18 00:15 | | Pfizer May File for Emergency Authorization of Coronavirus Vaccine Within the Week and more... |
| 2020-11-17 12:15 | | HHS issues rare 'fraud alert' encouraging pharma to nix paid doctor speaker programs and more... |
| 2020-11-17 00:15 | | Bristol Myers' $9 Celgene CVR is teetering on the brink of disaster as the FDA delays the liso-cel application yet again and more... |
| 2020-11-16 12:15 | | Moderna's COVID-19 vaccine aces phase 3, with no severe cases and more... |
| 2020-11-16 00:15 | | [video+transcript]How Long Will It Take for Coronavirus Vaccines to Help the U.S. Move Past the Pandemic? and more... |
| 2020-11-15 00:15 | | Can Pfizer's COVID-19 Vaccine End the Pandemic? BioNTech's CEO Believes So and more... |
| 2020-11-14 00:15 | | After WHO trial failure, influential medical group advises against Gilead's remdesivir in COVID critical care: Reuters and more... |
| 2020-11-13 00:15 | | Pfizer says placebo patients will eventually get its Covid-19 vaccine. The question of when is complicated and more... |
| 2020-11-12 12:15 | | Bayer powers gene-editing startup Metagenomi to $65M A round and more... |
| 2020-11-12 00:15 | | Vir Bio’s COVID-19 Antibody Therapy Could be Great, But Will It Be Too Late? and more... |
| 2020-11-11 12:15 | | Lucky Pfizer CEO Bourla cashes out $5.6M worth of stock—perfectly legally—as COVID vaccine data lifts market and more... |
| 2020-11-11 00:15 | | U.S. Supreme Court justices appear unlikely to throw out Obamacare and more... |
| 2020-11-10 12:15 | | Game on: Pfizer, BioNTech prepare to put COVID-19 shot distribution plan to the test after interim readout and more... |
| 2020-11-10 00:15 | | FDA greenlights first diagnostic test for COVID-19 antibodies that block the virus from entering cells and more... |
| 2020-11-09 12:15 | | GSK reports its long-acting HIV PrEP tops Gilead's Truvada — again and more... |
| 2020-11-08 00:15 | | Biden promises to roll out a Covid-19 task force on Monday and more... |
| 2020-11-07 00:15 | | FDA advisers vote against Biogen's Alzheimer's drug, leaving its future in doubt and more... |
| 2020-11-06 12:15 | | Novo Nordisk to boost pill-form diabetic drugs with $1.8 billion deal and more... |
| 2020-11-05 12:15 | | Merck inks $2.8B VelosBio buyout to snag anti-ROR1 ADC and more... |
| 2020-11-05 00:15 | | COVID antigen tests carry false positive risk: FDA and more... |
| 2020-11-04 12:15 | | FDA scientists appear to offer major endorsement of Biogen’s controversial Alzheimer’s treatment and more... |
| 2020-11-04 00:15 | | The meeting that could change Alzheimer's treatment and more... |
| 2020-11-03 12:15 | | Biogen's reprieve as critic recused from aducanumab panel, but analysts still read rejection in the tea leaves and more... |
| 2020-11-03 00:15 | | J&J plans to test its COVID-19 vaccine in ages 12-18 soon and more... |
| 2020-11-02 12:15 | | Sanofi inks $358M Kiadis takeover to acquire NK-cell platform and more... |
| 2020-11-02 00:15 | | Medtronic paying DOJ $9.2M to settle restaurant kickback allegations and more... |
